equityflowunderstand the flow and follow it
EquityFlow › Companies › Enara Bio

Enara Bio

Biotech · Oxford, GB

Developing Dark Antigen-based cancer immunotherapies.

In the network

Shares the most investors with (number = shared investors):
STORM Therapeutics 2

Funding history

DateRoundAmount
Oct 2024Series B
Enara Bio, an Oxford cancer-immunotherapy biotech, raised a $32.5M Series B co-led by Pfizer Ventures and M Ventures.
$32.5M

Investors

Tap an investor to see what else they have backed.

M VenturesPfizer Ventures

Other companies in Biotech

ImperagenHaga BiosciencePixelgen TechnologiesGallantChai DiscoverySNIPR BiomeCellbox LabsScope BiosciencesGenLuminaActitheraNUCLIDIUMAnocca

Other companies in GB

Capsa AI01HealthRem3dy HealthNewOrbitJoyvié HealthFuse EnergyAirspeedSembleWordsmithOxford Quantum CircuitsFreshaImperagen

Other companies at Series B stage

0x Labs11x.ai1K Kirana1X Technologies1plusX3Commas3SC4baseCare4screen8fig9finACALL
Explore funding flow on EquityFlow →

Data is community-curated and may be incomplete.